Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
Abstract Background Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e3c0cb32a2d42dabacb2b2e3626ff14 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2e3c0cb32a2d42dabacb2b2e3626ff14 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2e3c0cb32a2d42dabacb2b2e3626ff142021-11-21T19:38:53ZTargeted exome analysis of Russian patients with hypertrophic cardiomyopathy2324-926910.1002/mgg3.1808https://doaj.org/article/2e3c0cb32a2d42dabacb2b2e3626ff142021-11-01T00:00:00Zhttps://doi.org/10.1002/mgg3.1808https://doaj.org/toc/2324-9269Abstract Background Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients with HCM, and the spectrum of pathogenic variants that contribute to the development of HCM in Russia has not been fully described. Therefore, the goal of our study was to identify genetic variants associated with the etiopathogenesis of HCM in Russian patients. Methods The study cohort included 98 unrelated adult patients with HCM. We performed targeted exome sequencing, an analysis using various algorithms for prediction of the impact of variants on protein structure and the prediction of pathogenicity using ACMG Guidelines. Results The frequency of pathogenic and likely pathogenic variants in all HCM‐related genes was 8% in our patients. We also identified 20 variants of uncertain significance in all HCM‐related genes. Conclusions The prevalence of individual pathogenic variants in HCM‐related genes in Russian population appears to be lower than in general European population, which could be explained by ethnic features of Russian population, age characteristics of our sample, or unidentified pathogenic variants in genes previously not linked with HCM.Elena V. FilatovaNatalia S. KrylovaIvan N. VlasovMaria S. MaslovaNatalia G. PoteshkinaPetr A. SlominskyMaria I. ShadrinaWileyarticleexomegeneticshypertrophic cardiomyopathynext generation sequencingpathogenic variantsGeneticsQH426-470ENMolecular Genetics & Genomic Medicine, Vol 9, Iss 11, Pp n/a-n/a (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
exome genetics hypertrophic cardiomyopathy next generation sequencing pathogenic variants Genetics QH426-470 |
spellingShingle |
exome genetics hypertrophic cardiomyopathy next generation sequencing pathogenic variants Genetics QH426-470 Elena V. Filatova Natalia S. Krylova Ivan N. Vlasov Maria S. Maslova Natalia G. Poteshkina Petr A. Slominsky Maria I. Shadrina Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
description |
Abstract Background Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients with HCM, and the spectrum of pathogenic variants that contribute to the development of HCM in Russia has not been fully described. Therefore, the goal of our study was to identify genetic variants associated with the etiopathogenesis of HCM in Russian patients. Methods The study cohort included 98 unrelated adult patients with HCM. We performed targeted exome sequencing, an analysis using various algorithms for prediction of the impact of variants on protein structure and the prediction of pathogenicity using ACMG Guidelines. Results The frequency of pathogenic and likely pathogenic variants in all HCM‐related genes was 8% in our patients. We also identified 20 variants of uncertain significance in all HCM‐related genes. Conclusions The prevalence of individual pathogenic variants in HCM‐related genes in Russian population appears to be lower than in general European population, which could be explained by ethnic features of Russian population, age characteristics of our sample, or unidentified pathogenic variants in genes previously not linked with HCM. |
format |
article |
author |
Elena V. Filatova Natalia S. Krylova Ivan N. Vlasov Maria S. Maslova Natalia G. Poteshkina Petr A. Slominsky Maria I. Shadrina |
author_facet |
Elena V. Filatova Natalia S. Krylova Ivan N. Vlasov Maria S. Maslova Natalia G. Poteshkina Petr A. Slominsky Maria I. Shadrina |
author_sort |
Elena V. Filatova |
title |
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_short |
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_full |
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_fullStr |
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_full_unstemmed |
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_sort |
targeted exome analysis of russian patients with hypertrophic cardiomyopathy |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/2e3c0cb32a2d42dabacb2b2e3626ff14 |
work_keys_str_mv |
AT elenavfilatova targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT nataliaskrylova targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT ivannvlasov targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT mariasmaslova targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT nataliagpoteshkina targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT petraslominsky targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT mariaishadrina targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy |
_version_ |
1718418692548591616 |